InsidersTradesSigma
Track the ペプチドリーム株式会社 share price and the full directors' dealings record of the company, a publicly traded company based in Japan. Shares trade on JP JP, under the supervision of EDINET (Japan FSA). Operating in the Health Care sector, ペプチドリーム株式会社 has logged 11 public disclosures. Market capitalisation: €125.3bn. The latest transaction was filed on 23 March 2026 (Holding update). Among the most active insiders: M&G Investment Management Limited. Every trade is accessible without an account.
Analysts rate ペプチドリーム株式会社 Strong Buy (bullish), based on 6 analysts. Average price target: JP¥2,833.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations
Peptidream is a company focused on the development of peptides for pharmaceutical applications. It is listed on the XTKS market.